Acute Illness Requiring to Hospital Telemetry AdmissionNCT05534516
A Study of Physiologic Changes in a Telemetry Unit
An observational study of Acute Illness Requiring to Hospital Telemetry Admission, run by Mayo Clinic at 1 site in United States.
Trial summary
The purpose of this study is to determine the physiological changes associated with health deterioration, as well as different types, doses, and routes of administration of medications and fluids in acutely ill patients. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Acute Illness Requiring to Hospital Telemetry Admission
- How many people
- 500 participants
- Where
- 1 siteUnited States
- Study dates
- 22 Feb 2023to Aug 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients (18-65 years) admitted to the telemetry unit at Mayo Clinic Florida's Hospital with acute illness followed from admission to discharge.
Who may be able to join
- Admitted to telemetry unit
- With acute illness
- Received any type of medication via any route of administration (oral, sublingual, intranasal, inhalational, intramuscular, intravenous, subcutaneous, transdermal)
- Received any amount of any type of intravenous fluids
- Cognitively and/or physically be able to sign consent
Who cannot join
- None
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Physiologic Changes Associated With Health Deterioration, Medications and Fluids Used in the Telemetry Unit
The purpose of this study is to determine the physiological changes associated with health deterioration, as well as different types, doses, and routes of administration of medications and fluids in acutely ill patients.
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Heart Rate
Number of beats per minute
Measured: Baseline, through telemetry unit stay (approximately 1-3 days)
Change in Blood Pressure
Measured in millimeters of mercury (mmHg)
Measured: Baseline, through telemetry unit stay (approximately 1-3 days)
Change in Respiratory Rate
Number of breaths per minute
Measured: Baseline, through telemetry unit stay (approximately 1-3 days)
Change in Oxygen Saturation Levels
Measured by a pulse oximeter reading reported as a percentage
Measured: Baseline, through telemetry unit stay (approximately 1-3 days)
Change in ECG morphology
Changes in ECG waveform appearance measured from the digital ECG waveform interpretation
Measured: Baseline, through telemetry unit stay (approximately 1-3 days)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Sep 2022
- Study start22 Feb 2023
- Primary completionAug 2028 (estimated)
- Study completionAug 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Illness Requiring to Hospital Telemetry AdmissionStudies of the same condition, open and under way.
- More trials run by Mayo ClinicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Antonio J. Forte, Mayo Clinic
- Investigators
- Antonio Forte, MD, PhD, Principal investigator, Mayo Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05534516
- Sponsor's protocol ID
- 22-006064
- Status last verified
- Sep 2026
- First submitted
- 6 Sep 2022
- Last updated
- 9 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Physiologic Changes Associated With Health Deterioration, Medications and Fluids Used in the Telemetry Unit
- ClinicalTrials.gov ID
- NCT05534516
- Acronym / sponsor ID
- 22-006064
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Mayo ClinicUniversity, hospital or other
- Study start
- 22 Feb 2023 (actual)
- Primary completion
- Aug 2028 (estimated)
- Study completion
- Aug 2029 (estimated)
- First posted
- 9 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine the physiological changes associated with health deterioration, as well as different types, doses, and routes of administration of medications and fluids in acutely ill patients.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients (18-65 years) admitted to the telemetry unit at Mayo Clinic Florida's Hospital with acute illness followed from admission to discharge.
Key inclusion criteria (5 listed)
- Admitted to telemetry unit
- With acute illness
- Received any type of medication via any route of administration (oral, sublingual, intranasal, inhalational, intramuscular, intravenous, subcutaneous, transdermal)
- Received any amount of any type of intravenous fluids
- Cognitively and/or physically be able to sign consent
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Change in Heart Rate
Time frame: Baseline, through telemetry unit stay (approximately 1-3 days)
Number of beats per minute
Change in Blood Pressure
Time frame: Baseline, through telemetry unit stay (approximately 1-3 days)
Measured in millimeters of mercury (mmHg)
Change in Respiratory Rate
Time frame: Baseline, through telemetry unit stay (approximately 1-3 days)
Number of breaths per minute
Change in Oxygen Saturation Levels
Time frame: Baseline, through telemetry unit stay (approximately 1-3 days)
Measured by a pulse oximeter reading reported as a percentage
Change in ECG morphology
Time frame: Baseline, through telemetry unit stay (approximately 1-3 days)
Changes in ECG waveform appearance measured from the digital ECG waveform interpretation
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2026.
- Mayo Clinic Clinical TrialsLink provided by the sponsor.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Antonio Forte, MD, PhD principal investigator
Mayo Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Illness Requiring to Hospital Telemetry Admission, run by Mayo Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 9 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Heart Rate (time frame: Baseline, through telemetry unit stay (approximately 1-3 days)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2026.